Envista Holdings Corp Stock Price, News & Analysis

Envista Holdings (NYSE: NVST) has announced it will release its first quarter 2025 financial results on Thursday, May 1, 2025. The company will host a conference call and webcast to discuss the results on the same day at 2:00 PM PT.

The one-hour earnings call will be accessible via phone (800-225-9448 within U.S., +1 203-518-9708 outside U.S.) using conference ID #3526593. A webcast with accompanying slide presentation will be available on the company's investor relations website, with materials posted before the call and a replay available for one year afterward.

DEXIS, a global dental imaging technology leader, has announced its participation in the International Dental Show (IDS) 2025 in Cologne, Germany. The company will showcase several innovations within its AI-powered digital ecosystem, including:

- Imprevo: A new high-performance intraoral scanner with rebuilt hardware and AI-powered algorithm

- IS ScanFlow 2.0: Updated software featuring a new Smile Visualizer tool for treatment previews

- ORTHOPANTOMOGRAPH OP 3D EX updates with new cephalometric imaging capabilities

- Automatic Dose Control feature for the ORTHOPANTOMOGRAPH OP 3D LX

- DTX Studio Clinic enhancements including automated implant planning, 3-minute surgical template generation, and upcoming AI-driven endodontic capabilities

The company will demonstrate these technologies at Hall 11.2 K050 L069, highlighting their integration into DEXIS's comprehensive digital workflow solution that currently has over 165,000 installations worldwide.

Envista Holdings (NYSE: NVST) announced that its Envista Smile Project contributed $1.8 million in 2024 to improve oral health accessibility for underserved communities. Since 2021, the project has provided over $4.2 million in dental goods and services, helping approximately 32,000 individuals globally.

Key 2024 achievements include:

• Provided free dental care to 787 patients in Dominican Republic
• Donated dental supplies to clinics serving over 5,600 patients
• Supplied portable x-ray access to multiple Mission of Mercy events
• Partnered with USC's Herman Ostrow School of Dentistry
• Sponsored five senior residents for Jamaica mission treating 1,661 patients

Envista Holdings (NYSE: NVST) reported Q4 2024 results with sales of $653 million and core sales growth of 2.0% compared to Q4 2023. The company achieved an Adjusted EBITDA margin of 13.9% and demonstrated improved performance in implants across Nobel Biocare, Implant Direct, and Alpha-Bio brands. Spark aligners showed continued market share gains and gross margin improvement.

Financial highlights include operating cash flow of $132 million and free cash flow of $124 million, representing increases of 30% and 24% respectively over Q4 2023. Q4 net income was $1 million ($0.01 per share), compared to a loss of $217 million in Q4 2023. For the full year 2024, the company reported a net loss of $1,119 million.

Looking ahead to 2025, Envista projects core sales growth of 1-3%, adjusted EBITDA margins of approximately 14%, and adjusted earnings per share between $0.95 and $1.05.

Envista Holdings (NYSE: NVST) has announced its upcoming Capital Markets Day, scheduled for Wednesday, March 5, 2025, from 9:00 a.m. to 12:00 p.m. EST. The event will feature a management presentation and a Q&A session.

In-person attendance will require advance registration through IR@envistaco.com. For those unable to attend physically, the event and presentation will be webcast and made available for replay on the Events and Presentations section of investors.envistaco.com.

DEXIS, a dental imaging technologies leader, reflects on its 2024 achievements and announces plans for 2025. Key 2024 launches included the DEXIS digital ecosystem for streamlined implant workflow, the Ti2 Intraoral Sensor with AI capabilities, DEXIS Connect Pro for proactive device monitoring, and the ORTHOPANTOMOGRAPH OP 3D EX X-ray platform.

The company plans several innovations for 2025, including their first in-house developed intraoral scanner, AI enhancements, 3D imaging portfolio expansion, and DTX Studio Clinic workflow updates. These developments will be showcased at the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne in March. Currently, over 150,000 DEXIS dental imaging devices are in use worldwide.

Envista Holdings (NYSE: NVST) has announced its upcoming fourth quarter 2024 financial results release, scheduled for Wednesday, February 5, 2025. The company has rescheduled its conference call to 2:30 PM PT on the same date.

The one-hour earnings call will be accompanied by a slide presentation and webcast available on the 'Investors' section of Envista's website. Participants can join via phone by dialing 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081. The webcast replay will be accessible for one year, and related materials will be posted on the company's website prior to the call.

Envista Holdings (NYSE: NVST) has scheduled its fourth quarter 2024 earnings conference call for Wednesday, February 5, 2025, at 2:00 PM PT. The call will include a slide presentation and is expected to last approximately one hour.

Investors can access the webcast through the 'Investors' section of www.envistaco.com. A replay will be available for one year following the presentation. For direct dial-in access, participants can call 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081.

The earnings press release, webcast slides, and related materials will be posted on Envista's website before the conference call.

Envista Holdings (NYSE: NVST) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. An audio-only recording of the presentation will be available on Envista's Investor Relations website for 30 days following the event.